# US 2024/0306694 A1 · Uses of bifidobacterium longum transitional microorganism

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0306694 A1
- Document ID: US20240306694A1
- Status: Published application
- Kind: A1
- Application number: 18/577,141
- Filed: 2022-07-08
- Published: 2024-09-19
- Earliest claimed: 2021-07-09
- Assignees: Societe des Produits Nestle S.A.
- Applicants: Societe Des Produits Nestle S.A.
- Inventors: OLGA SAKWINSKA; STEPHANE DUBOUX; CATHERINE NGOM-BRU; NORBERT SPRENGER
- Web page: https://patentgrep.com/patent/US20240306694A1

## CPC

- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A23L 33/21: Addition of substantially indigestible substances, e.g. dietary fibres
- A61K 31/702: Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A61K 35/745: Bifidobacteria
- C12N 1/20: Bacteria; Culture media therefor
- A23V 2400/533: Longum
- C12Y 302/01063: 1,2-Alpha-L-fucosidase (3.2.1.63)
- C12Y 302/01111: 1,3-Alpha-L-fucosidase (3.2.1.111), i.e. 1,3-alpha-fucosidase
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- C12Y: ENZYMES

## Abstract

The present invention relates to use of a B. longum transitional microorganism that has a preferential utilization of 3-FL over 2′FL. It also relates to methods and to a composition comprising the B. longum transitional microorganism and uses thereof.

## Claims

### Claim 1

(canceled)

### Claim 2 (depends on 9)

Method according to claim 9 wherein the Bidobacterium longum microorganism has an Average Nucleotide Identity (ANI) of at least 96% with at least one Bifidobacterium longum strain selected in the group consisting of CNCM I-5683, CNCM I-5684, CNCM I-5685, CNCM I-5686 and CNCM I-5687, and any combination thereof.

### Claim 3 (depends on 9)

Method according to claim 9, wherein the Bifidobacterium longum transitional microorganism comprises a glycosyl hydrolase family 95 (GH95, α-L-galactosidase; α-L-fucosidase; α-1,2-L-fucosidase) gene having at least 60% of identity with BLON 2335 gene present in Bifidobacterium longum subsp. infantis ATCC 15697 and/or a glycosyl hydrolase family 29 (GH29, α-L-fucosidase; α-1,3/1,4-L-fucosidase; α-1,2-L-fucosidase) having at least 60% identity with BLON_2336 gene present in Bifidobacterium longum subsp. infantis ATCC 15697.

### Claim 4 (depends on 9)

Method according to claim 9, wherein 3-fucosyllactose (3-FL) is utilized by the Bifidobacterium longum transitional microorganism over 2′-fucosyllactose (2′-FL) in a ratio between 0.1:5.

### Claim at position 5

5-7. (canceled)

### Claim 8

A method of promoting the growth of a Bidobacterium longum transitional microorganism to modulate the gut microbiota of an infant and/or of a young child, the method comprising administering to the infant and/or to the young child a composition comprising a Bifidobacterium longum transitional microorganism, wherein the Bidobacterium longum transitional microorganism is capable of utilizing prebiotic oligosaccharides and wherein the Bifidobacterium longum transitional microorganism preferentially utilizes 3-fucosyllactose (3-FL) over 2′-fucosyllactose (2′-FL).

### Claim 9

A method of promoting/assisting the transition from a milk-based diet to solid food in an infant and/or in a young child, the method comprising administering to the infant and/or to the young child a composition comprising a Bifidobacterium longum transitional microorganism, wherein the Bifidobacterium longum transitional microorganism is capable of utilizing prebiotic oligosaccharides and wherein the Bifidobacterium longum transitional microorganism preferentially utilizes 3-fucosyllactose (3-FL) over 2′-fucosyllactose (2′-FL).

### Claim 10

(canceled)

### Claim 11 (depends on 8)

Method according to claim 8 wherein the composition comprises at least one prebiotic oligosaccharide selected in the group consisting of 2′-O-fucosyllactose (2FL), 3′-O-fucosyllactose (3FL), lactodifucotetraose/difucosyllactose (DFL), 3′-O-sialyllactose (3-SL), 6′-O-sialyllactose (6′-SL) and lacto-N-tetraose (LNT) and any combination thereof.

### Claim 12 (depends on 9)

Method according to claim 9 wherein the composition comprises 34 wt % to 85 wt % of 2′-FL, 10 wt % to 40 wt % of LNT, 4 wt % to 14 wt % of DFL and 9 wt % to 31 wt % of 3-SL and 6′-SL combined.

### Claim at position 11

13-17. (canceled)

### Claim 18

A method of promoting the growth of the Biidobacterium longum transitional microorganism that preferentially utilizes 3-fucosyllactose (3-FL) over 2′-fucosyllactose (2′-FL) to modulate the gut microbiota of an infant and/or of a young child, the method comprising administering to the infant and/or to the young child a composition comprising a Bifidobacterium longum transitional microorganism, wherein the Bifidobacterium longum transitional microorganism is capable of utilizing prebiotic oligosaccharides and wherein the Bifidobacterium longum transitional microorganism preferentially utilizes 3-fucosyllactose (3-FL) over 2′-fucosyllactose (2′-FL).

### Claim 19

(canceled)
